McKesson Corporation $MCK Stock Position Boosted by Nisa Investment Advisors LLC

Nisa Investment Advisors LLC increased its holdings in shares of McKesson Corporation (NYSE:MCK) by 14.5% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 49,011 shares of the company’s stock after purchasing an additional 6,190 shares during the period. Nisa Investment Advisors LLC’s holdings in McKesson were worth $41,891,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also modified their holdings of the business. Secure Asset Management LLC lifted its stake in McKesson by 484.8% in the second quarter. Secure Asset Management LLC now owns 2,123 shares of the company’s stock valued at $1,604,000 after buying an additional 1,760 shares in the last quarter. Royal London Asset Management Ltd. boosted its holdings in shares of McKesson by 1.1% in the second quarter. Royal London Asset Management Ltd. now owns 112,241 shares of the company’s stock valued at $84,809,000 after buying an additional 1,216 shares during the period. Benchmark Investment Advisors LLC acquired a new position in shares of McKesson in the second quarter valued at approximately $441,000. Summit Global Investments bought a new stake in shares of McKesson during the second quarter worth $1,159,000. Finally, One Wealth Advisors LLC bought a new stake in shares of McKesson during the second quarter worth $1,494,000. 85.07% of the stock is currently owned by institutional investors and hedge funds.

More McKesson News

Here are the key news stories impacting McKesson this week:

• Positive Sentiment: UBS raised its price target to $1,200, implying additional upside and reinforcing the bullish view on McKesson’s pharmaceutical distribution and healthcare-services businesses. UBS raises target for McKesson stock
• Positive Sentiment: Leerink raised its target from $1,030 to $1,070, adding to a series of upward revisions from analysts. Leerink raises McKesson price target
• Positive Sentiment: McKesson recently reported quarterly earnings and revenue above consensus estimates. EPS was $9.93 versus $9.56 expected, while revenue reached $105.38 billion, up 7.7% year over year. Management’s fiscal 2027 EPS guidance of $44.20–$45.00 also supports the growth narrative. McKesson outperforms broader market
• Neutral Sentiment: Mizuho lifted its price target from $905 to $1,020 but maintained a “neutral” rating. The revised target is close to, but below, the current market valuation, suggesting limited near-term upside in that analyst’s view. Mizuho adjusts McKesson price target
• Negative Sentiment: Executive Vice President Francisco Fraga sold 800 shares worth approximately $796,640. However, the transaction was conducted under a pre-arranged Rule 10b5-1 plan, reducing its significance as a discretionary bearish signal. McKesson executive stock sale

Insider Buying and Selling

In related news, EVP Francisco Fraga sold 800 shares of the stock in a transaction on Thursday, October 15th. The shares were sold at an average price of $995.80, for a total transaction of $796,640.00. Following the completion of the transaction, the executive vice president owned 5,423 shares in the company, valued at approximately $5,400,223.40. This represents a 12.86% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CAO B Jr sold 111 shares of the firm’s stock in a transaction on Tuesday, September 8th. The shares were sold at an average price of $891.45, for a total transaction of $98,950.95. Following the completion of the transaction, the chief accounting officer directly owned 521 shares of the company’s stock, valued at approximately $464,445.45. This trade represents a 17.56% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last 90 days, insiders sold 1,212 shares of company stock worth $1,164,182. 0.06% of the stock is owned by insiders.

McKesson Stock Up 1.9%

NYSE:MCK opened at $1,029.52 on Wednesday. McKesson Corporation has a twelve month low of $723.68 and a twelve month high of $1,030.27. The business has a 50 day moving average price of $902.90 and a two-hundred day moving average price of $839.47. The company has a market cap of $120.03 billion, a P/E ratio of 27.55, a price-to-earnings-growth ratio of 2.01 and a beta of 0.30.

McKesson (NYSE:MCK) last issued its quarterly earnings results on Wednesday, August 5th. The company reported $9.93 earnings per share for the quarter, topping the consensus estimate of $9.56 by $0.37. McKesson had a net margin of 1.12% and a negative return on equity of 253.21%. The company had revenue of $105.38 billion during the quarter, compared to analysts’ expectations of $103.88 billion. During the same period last year, the business earned $8.26 EPS. The business’s quarterly revenue was up 7.7% on a year-over-year basis. McKesson has set its FY 2027 guidance at 44.200-45.000 EPS. As a group, analysts anticipate that McKesson Corporation will post 44.71 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

A number of equities research analysts recently commented on the stock. Citigroup raised their price objective on shares of McKesson from $945.00 to $1,000.00 and gave the stock a “buy” rating in a report on Friday, July 24th. Bank of America boosted their price objective on shares of McKesson from $950.00 to $1,050.00 in a research report on Thursday, August 6th. Leerink Partners upped their target price on shares of McKesson from $1,030.00 to $1,070.00 and gave the stock an “outperform” rating in a research note on Wednesday, October 7th. Morgan Stanley set a $977.00 target price on shares of McKesson in a research note on Tuesday, October 6th. Finally, Argus increased their target price on McKesson from $850.00 to $970.00 and gave the stock a “buy” rating in a report on Thursday, September 3rd. Fifteen equities research analysts have rated the stock with a Buy rating and four have issued a Hold rating to the company. According to MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus price target of $997.12.

About McKesson

McKesson Corporation is a healthcare services and information technology company that distributes pharmaceuticals and medical products to pharmacies, hospitals, health systems, physicians and other healthcare providers. The company also provides technology, data and business solutions designed to support prescription management, pharmacy operations and patient care.

McKesson’s principal activities include pharmaceutical distribution, medical-surgical supply distribution, specialty pharmaceutical services and oncology care support.